Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

SEHK:2315 Stock Report

Market Cap: HK$2.4b

Biocytogen Pharmaceuticals (Beijing) Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2315 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24BuyHK$4,094,998Veken Holding Group CO., LTD.Company700,000HK$5.85

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2315?
Owner TypeNumber of SharesOwnership Percentage
Private Companies49,677,90012.4%
Employee Share Scheme54,695,16013.7%
Individual Insiders55,399,68013.9%
General Public58,024,76014.5%
VC/PE Firms75,921,48019%
Institutions105,679,44026.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 85.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.3%
UBS SDIC Fund Management Co., Ltd.
72,937,440HK$439.8m0%1.46%
13.7%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd, ESOP
54,695,160HK$329.8m0%no data
8.04%
CMB International Capital Management (Shenzhen) Co, Ltd.
32,110,920HK$193.6m0%2.08%
7.26%
Jian Ni
29,004,840HK$174.9m0%no data
6.61%
Yuelei Shen
26,394,840HK$159.2m0%no data
6.53%
Astral Eminent Limited
26,088,480HK$157.3m0%no data
5.89%
China Life Insurance (Group) Company Limited, Asset Management Arm
23,519,160HK$141.8m0%33.23%
5.89%
China Life Private Equity Investment Co., Ltd.
23,519,160HK$141.8m0%1.62%
5.08%
BVCF Management Ltd
20,291,400HK$122.4m0%38.93%
4.77%
Shenzhen Zhaoyin Chengzhang Shijiuhao Equity Investment Fund Partnership
19,060,920HK$114.9m0%no data
2.31%
New China Life Insurance Co., Ltd., Asset Management Arm
9,222,840HK$55.6m0%0.44%
1.13%
Veken Holding Group CO., LTD.
4,528,500HK$27.3m0%no data